Muskegon Chronicle – MLive.comAmerican Red Cross blood drives in November 2012 for Muskegon, Newaygo …Muskegon Chronicle – MLive.com13, 2012, 10 a.m. to 3:45 p.m., Muskegon Blood Donation Center, 313 W. Webster Ave., Muskegon. Nov. 15, 2012, 1-6:45 p…
Novartis new two-year data with Certican(R) shows positive outcomes at 24 … – Reuters
Novartis new two-year data with Certican(R) shows positive outcomes at 24 …ReutersCalcineurin inhibitors like tacrolimus are part of the standard immunosuppression regimen after a liver transplant but may contribute to a decline in renal function ove…
Orgenesis Enters Into R&D Agreement With The Fraunhofer IGB – Business Wire (press release)
Orgenesis Enters Into R&D Agreement With The Fraunhofer IGBBusiness Wire (press release)“We are very excited to support Orgenesis in their development of a very promising new therapy for diabetes that overcomes the problem of donor shortage and r…
St. Louis doctor helping women preserve chance at motherhood – STLtoday.com
St. Louis doctor helping women preserve chance at motherhoodSTLtoday.comThe young woman from London wanted a risky stem cell transplant to treat her multiple sclerosis. She knew the chemotherapy involved with the transplant probably would leave her inf…
Lung transplant recipient meets donor's mom after half marathon
A former Navy SEAL finished a half marathon Saturday — then met the stranger he credits for saving his life.
Novartis announces encouraging results from Phase III heart failure study – Equities.com
Novartis announces encouraging results from Phase III heart failure studyEquities.comNov 12, 2012 (Datamonitor via COMTEX) — Novartis AG has announced that Phase III RELAX-AHF study has shown that investigational RLX030 improved symptoms and reduced d…
New Kidney Allocation Proposal Is Ethically Unacceptable – U.S. News & World Report
U.S. News & World ReportNew Kidney Allocation Proposal Is Ethically UnacceptableU.S. News & World ReportFirst, individuals with ESRD have two therapeutic options: dialysis or kidney transplantation. Second, virtually all individuals with ESRD, regardle…
Reuters Health News Summary
Following is a summary of current health news briefs. Novartis drug helps patients with rare inflammatorydiseases ZURICH (Reuters) – Novartis' Ilaris helps reducepatients' symptoms and the frequency of attacks in two rareinflammatory diseases, …
CellAegis Devices Announces Initiation of Clinical Testing of Remote Ischemic … – MarketWatch (press release)
CellAegis Devices Announces Initiation of Clinical Testing of Remote Ischemic …MarketWatch (press release)The study design for the Toronto clinical program calls for the enrollment of 24 adult patients with stage T1 renal cell carcinoma (RCC) schedul…
Intercept Pharmaceuticals Announces Completion of Enrollment in FLINT
NEW YORK — Intercept Pharmaceuticals, Inc. (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, …